Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Pharmaceuticals ETF

105.16
+1.181.13%
Volume:291.74K
Turnover:30.65M
Market Cap:1.71B
PE:9.80
High:106.25
Open:104.58
Low:104.57
Close:103.98
52wk High:108.66
52wk Low:69.02
Shares:16.30M
Float Shares:16.30M
Volume Ratio:1.15
T/O Rate:1.79%
Dividend:1.47
Dividend Rate:1.40%
EPS(TTM):10.74
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Pharma Stocks Have Rallied. 2 Stocks to Avoid-and 2 to Buy.

Dow Jones
·
Aug 21

Johnson & Johnson Says Multiple Myeloma Treatment Approved by European Commission

MT Newswires Live
·
Aug 21

African Markets - Factors to Watch on Aug 21

Reuters
·
Aug 21

Moderna’s Personalized MRNA Shot Could Reshape the Fight Against Skin Cancer — but It May Also Be Overhyped

Dow Jones
·
Aug 21

Perrigo Co. PLC Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 21

Does J&J’s MONARCH QUEST 3 Approval and MedTech Momentum Change The Bull Case For Johnson & Johnson (JNJ)?

Simply Wall St.
·
Aug 21

Thursday's Top 20 US Stock Transactions: Micron Rises 3.97% Following $10 Billion Research Lab Announcement

Deep News
·
Aug 21

Bristol Myers Squibb Co. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 21

Bristol-Myers Squibb Co Stock (BMY) Closed Down by 3.17% on Aug 20: Facts Behind the Movement

TradingKey
·
Aug 21

Moderna is up 350% Since Our Recommendation. Here's What to Do Next.

Dow Jones
·
Aug 21

Sector Update: Healthcare Stocks Fall Thursday Afternoon

MT Newswires Live
·
Aug 21

Congo Set to Receive 70,000 Ervebo Vaccines to Contain Ebola Outbreak, WHO Says

Reuters
·
Aug 21

Gavi Announces $7 Mln Funding for Shipment of 70,000 Doses of Ervebo Vaccine to DRC

Reuters
·
Aug 21

Merck Stock (MRK) Is a Strong Buy Now as 3 Top Wall Street Analysts Hike Price Targets

TIPRANKS
·
Aug 21

Bristol‑Myers Squibb Advances Navlimetostat Metabolism Study, Signaling Steady Pipeline Progress

TIPRANKS
·
Aug 21

Eli Lilly Advances Early-Stage Eloralintide Trial: What Investors Should Watch

TIPRANKS
·
Aug 21

Eli Lilly’s Lebrikizumab Trial Completion Signals New Growth Path in Atopic Dermatitis

TIPRANKS
·
Aug 21

Merck is Maintained at Buy by UBS

Dow Jones
·
Aug 21

Why Merck Stock Got Downgraded After a Massive Cancer-Vaccine Win

Dow Jones
·
Aug 20

Merck's Momentum Remains Strong But Valuation Limits Further Upside, RBC Says

MT Newswires Live
·
Aug 20